Iran strongly condemned on Thursday an "insulting" poster on a bus in a French city depicting supreme leader Ayatollah Ali Khamenei, state media reported, with relations strained between the two ...

Iran yesterday condemned an “insulting” poster on a bus in a French city depicting Iranian supreme leader Ayatollah Ali Khamenei, state media reported. The city of Beziers in southern France had run a ...

Iran strongly condemned on Thursday an “insulting” poster on a bus in a French city depicting supreme leader Ali Khamenei, state media reported, with relations strained between the two countries.

The city of Beziers in southern France had run a campaign on buses calling for selective sorting of waste using portraits of Iran's Khamenei, Russian President Vladimir Putin, and North Korean ...

Investing.com -- Short seller Scorpion Capital disclosed a short position in TransMedics Group Inc (NASDAQ:TMDX) accusing the organ transplant tech. company of fraudulent practices, including ...

Ah, the scorpion lollipop, a symbol of the Sonoran Desert. I like them, if only for the campiness of the dark, goth-looking scorpion encased unhappily in a gentle green, pink or blue. That said, ...

We look forward to leveraging the great work of the Scorpion team to date, along with Lilly's deep expertise in breast cancer, to further advance STX-478 with speed and focus." Under the terms of ...

Eli Lilly (NYSE:LLY) is in advanced discussions to purchase cancer-focused biotech Scorpion Therapeutics for as much as $2.5 billion. A deal is likely to be reached in the coming days ahead of the ...

Tim Kaine, a Democrat, one Republican member of the committee spent too much time praising Hegseth and not enough time proofreading his prop poster — the poster misspelled the word military as ...

Eli Lilly is reenergizing its attempt to challenge Novartis and Roche for a breast cancer market, kicking off the J.P. Morgan Healthcare Conference with a deal to buy Scorpion Therapeutics ...

Eli Lilly has agreed to acquire Scorpion Therapeutics’ breast cancer treatment program for up to $2.5 billion in cash. The drugmaker said Monday it is acquiring Scorpion and its STX-478 program ...